Body Weight Cutoff for Daily Dosage of Efavirenz and 60-Week Efficacy of Efavirenz-Based Regimen in Human Immunodeficiency Virus and Tuberculosis Coinfected Patients Receiving Rifampin

Seventy-one human immunodeficiency virus-infected patients with tuberculosis who were receiving a rifampin (rifampicin)-containing regimen were initiated on treatment with efavirenz at 600 mg/day plus stavudine-lamivudine. Fasting efavirenz concentrations at 12 h after dosing (C(12)) were monitored....

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Manosuthi, Weerawat, Sungkanuparph, Somnuek, Tantanathip, Preecha, Mankatitham, Wiroj, Lueangniyomkul, Aroon, Thongyen, Supeda, Eampokarap, Boonchuay, Uttayamakul, Sumonmal, Suwanvattana, Pawita, Kaewsaard, Samroui, Ruxrungtham, Kiat
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: American Society for Microbiology (ASM) 2009
Θέματα:
Antiviral Agents
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2764182/
https://ncbi.nlm.nih.gov/pubmed/19667281
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00492-09
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια